oleic acid has been researched along with 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, BJ; Du, JD; Liu, Q; Nguyen, TH; Salentinig, S | 1 |
| Bisset, NB; Boyd, BJ; Dong, YD | 1 |
| Heeralal, B; Jain, S; Kushwah, V; Swami, R; Swarnakar, NK | 1 |
3 other study(ies) available for oleic acid and 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol
| Article | Year |
|---|---|
A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa.
Topics: Adhesiveness; Animals; Colloids; Cryoelectron Microscopy; Drug Carriers; Drug Stability; Fatty Alcohols; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Lipids; Microscopy, Confocal; Microscopy, Electron, Transmission; Mouth Mucosa; Nanoparticles; Oleic Acid; Particle Size; Phase Transition; Surface Properties; Sus scrofa; Triamcinolone | 2014 |
Tailoring liquid crystalline lipid nanomaterials for controlled release of macromolecules.
Topics: Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Fatty Alcohols; Hydrogen-Ion Concentration; Liquid Crystals; Macromolecular Substances; Nanostructures; Oleic Acid; Sucrose; Water | 2015 |
Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles.
Topics: Animals; Antineoplastic Agents, Hormonal; Biological Availability; Caco-2 Cells; Cell Proliferation; Chemical and Drug Induced Liver Injury; Delayed-Action Preparations; Drug Compounding; Fatty Alcohols; Female; Glycerides; Humans; Liquid Crystals; MCF-7 Cells; Nanoparticles; Oleic Acid; Particle Size; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen | 2018 |